← back to search

Tristan Mirault

Centre Pompidou · FR
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Peripheral Artery Disease Management, Venous Thromboembolism Diagnosis and Management, Vasculitis and related conditions, and COVID-19 Clinical Research Studies.
h-index
41
citations
12,202
works
299
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.
2025cited by 5position: contributordoi
Cutting-edge European guidelines for managing lower extremity peripheral arterial disease – Featuring selected insights on PAD management
VASA 2025cited by 4position: middledoi
Symptomatic Upper Extremity Peripheral Artery Disease is Associated With Poor Outcomes and a Broad Spectrum of Etiologies.
2025cited by 1position: contributordoi
Predictive factors for complete recovery of post-thrombotic syndrome 6 months after venous recanalization.
2025cited by 0position: contributordoi
Predictive factors for complete recovery of post-thrombotic syndrome 6 months after venous recanalization
European Journal of Vascular and Endovascular Surgery 2025cited by 0position: contributordoi
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.
2024cited by 462position: contributordoi
French protocol for the diagnosis and management of giant cell arteritis
La Revue de Médecine Interne 2024cited by 18position: middledoi
Impact of gender on self-assessment accuracy among fourth-year French medical students on faculty’s online Objective Structured Clinical Examinations
BMC Medical Education 2024cited by 9position: middledoi
L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift.
2024cited by 7position: contributordoi
Fluoroquinolone Use Preceding Visceral Artery Dissection: A Case Series.
2024cited by 0position: contributordoi
The fundamental mechanisms of the Korotkoff sounds generation.
2023cited by 11position: contributordoi
Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
2023cited by 8position: contributordoi
Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis.
2022cited by 24position: contributordoi
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study.
2022cited by 13position: contributordoi
Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.
2022cited by 10position: contributordoi
Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation.
2022cited by 1position: contributordoi
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients.
2021cited by 67position: contributordoi
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
2021cited by 46position: contributordoi
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study.
2021cited by 25position: contributordoi
Impact of integrating objective structured clinical examination into academic student assessment: Large-scale experience in a French medical school
PLoS ONE 2021cited by 23position: middledoi
Renal Outcome and New-Onset Renal and Extrarenal Dissections in Patients With Nontrauma Renal Artery Dissection Associated With Renal Infarction
Hypertension 2021cited by 12position: contributordoi
Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
2021cited by 9position: contributordoi
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak: A Practical Review.
2021cited by 5position: contributordoi
Cardiometabolic Disorders and the Risk of Critical COVID-19 as Compared to Influenza Pneumonia.
2021cited by 4position: contributordoi
Fluoroquinolones et risque vasculaire
JMV-Journal de Médecine Vasculaire 2021cited by 1position: contributordoi
Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers Danlos syndrome
2021cited by 0position: contributordoi
Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration
Journal of Thrombosis and Haemostasis 2020cited by 98position: middledoi
Traitement de l’artérite de Takayasu : place de l’imagerie dans l’exploration de la maladie et conséquences interventionnelles
Bulletin de l'Académie Nationale de Médecine 2020cited by 0position: contributordoi
Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study.
2019cited by 90position: contributordoi
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients.
2019cited by 68position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2020–2025)Guillaume Goudot · Sorbonne Paris Cité6 papers (2023–2025)Nicolas Gendron · Boston Children's Hospital6 papers (2021–2025)Xavier Jeunemaitre · Sorbonne Paris Cité4 papers (2021–2025)David M. Smadja · Vall d'Hebron Institut de Recerca4 papers (2021–2022)Salma Adham · Springer Nature3 papers (2021–2025)Emmanuel Messas · Laboratoire d’Imagerie Biomédicale3 papers (2021–2023)A. Bura-Rivière · Hôpital Edouard Herriot2 papers (2025–2025)Benjamin Planquette · Innovations Thérapeutiques en Hémostase2 papers (2022–2022)Pierre Boutouyrie · GTx (United States)2 papers (2019–2025)Jean-Sébastien Hulot · Johns Hopkins Hospital2 papers (2021–2021)Anne Legrand · Inserm2 papers (2021–2022)Juliette Hadchouel · Délégation Paris 52 papers (2021–2024)Lina Khider · Saint-Gobain (France)2 papers (2022–2022)Elie Mousseaux · Délégation Paris 52 papers (2021–2025)Pascale Gaussem · Délégation Paris 72 papers (2021–2021) · 2 papers (2022–2022)Irmine Ferreira · Université Paris Cité2 papers (2022–2024)Olivier Sanchez · University of South Alabama2 papers (2022–2022)Marc Al Ahmar · Institut national de recherche en sciences et technologies du numérique2 papers (2025–2025)